89
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEPreclinical Therapeutics

Immune Consequences of Protracted Host-Tumor Interactions in a Transgenic Mouse Model of Mammary Carcinoma

, &
Pages 237-249 | Published online: 11 Jun 2009
 

Abstract

A transgenic mouse model of autochthonous mammary carcinoma was chosen to study the impact of tumor progression on the immune system over an extended period. We found: i) that splenocyte numbers, particularly myeloid cells, increased concurrently with tumor burden; ii) the percentage of tumor-infiltrating Treg cells was similar to that in human breast cancer; iii) suppressed T cell proliferation and cytokine production and; iv) significantly elevated MCP-1 and TNF-α in the sera of tumor-bearing mice. The modified immune status in these tumor-bearing hosts is consistent with a “syndrome” that likely impacts the efficacy of cancer immunosurveillance and response to therapy.

ABBREVIATIONS
Ag=

antigen

CTL=

cytotoxic T lymphocyte

ConA=

Concanavalin A

LN=

Lymph node

LNC=

Lymph node cell

LPS=

Lipopolysaccharide

MCP-1=

monocyte-chemoattractant protein-1

MDSC=

myeloid derived suppressor cell

MTAG=

Middle T AntiGen

NKT=

natural killer T

TCR=

T cell receptor

TDLNs=

Tumor-draining lymph nodes

Tg+=

transgene positive

Tg=

transgene negative

TNF-α=

tumor-necrosis factor-α

Treg=

regulatory T cell

ABBREVIATIONS
Ag=

antigen

CTL=

cytotoxic T lymphocyte

ConA=

Concanavalin A

LN=

Lymph node

LNC=

Lymph node cell

LPS=

Lipopolysaccharide

MCP-1=

monocyte-chemoattractant protein-1

MDSC=

myeloid derived suppressor cell

MTAG=

Middle T AntiGen

NKT=

natural killer T

TCR=

T cell receptor

TDLNs=

Tumor-draining lymph nodes

Tg+=

transgene positive

Tg=

transgene negative

TNF-α=

tumor-necrosis factor-α

Treg=

regulatory T cell

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.